• No Specific Disease - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases

    Jun 1, 2021, 00:00

  • PCN244 Supervised Machine Learning for Predicting Mortality in Acute Myeloid Leukemia Patients Using Electronic Health Record Data

    Jun 1, 2021, 00:00

  • Cancer - Medical Technologies

    Jun 1, 2021, 00:00

  • Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017

    Jun 1, 2021, 00:00

  • PMU43 VALUE-Based Pricing in Colombia: The Devil Is in the Details

    Jun 1, 2021, 00:00

  • Economic Evaluation of New Models of Care: Does the Decision Change Between Cost-Utility Analysis and Multi-Criteria Decision Analysis?

    Jun 1, 2021, 00:00

  • Cancer - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PMU4 Bridging the Gap: Aligning Economic Research With Disease Burden

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PMU59 Predictors and Health Related Quality of Life Associated with Renal Diseases in Cancer Patients in United States

    Jun 1, 2021, 00:00

  • PCV48 Clinical Restrictions in Cardiac Health Technology Assessments

    Jun 1, 2021, 00:00

  • PCN53 Grade 3/4 Adverse Event (AE) Costs of Nivolumab Plus Ipilimumab (N+I) Versus Nivolumab Plus Cabozantinib (N+C) and Pembrolizumab Plus Axitinib (P+A) for Previously Untreated Advanced Renal Cell Carcinoma (aRCC)

    Jun 1, 2021, 00:00

  • PND49 An Assessment of Real-World Healthcare Provider Experiences with Insomnia Medications Focusing on Suvorexant in the United States (US)

    Jun 1, 2021, 00:00

  • PRO66 Health-Related Quality of Life in Persons with Sickle Cell Disease

    Jun 1, 2021, 00:00

  • PMU8 The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

    Jun 1, 2021, 00:00

  • PNS79 Milestones for HTA Institutionalization in Ukraine Due to International Practice

    Jun 1, 2021, 00:00

  • PND19 Healthcare Burden of Medication-Overuse Headache in Patients with Migraine

    Jun 1, 2021, 00:00

  • PCN205 IMPACT of Treatment Adherence on CORE Outcomes in Patients with Colorectal Cancer: A Systematic Review

    Jun 1, 2021, 00:00

  • PNS118 Real World Evidence (RWE) Use in Latin America Healthcare Decision Making: An Stakeholder Survey Analysis.

    Jun 1, 2021, 00:00

  • PNS7 Ongoing SLRs When Considering HTA Submissions: Rewards and Avoidable Pitfalls

    Jun 1, 2021, 00:00

  • PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL

    Jun 1, 2021, 00:00

  • PMU13 Economic Impact of Comorbidities in an Employer-Insured Migraine Population

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN184 Understanding the VALUE of Real-World Evidence (RWE) in Health Economics: Are Traditional Systematic Literature Reviews (SLRS) Omitting Key Evidence for Health Technology Assessment (HTA)?

    Jun 1, 2021, 00:00

  • PCN143 Real-World Assessment of the Treatment Patterns Associated with Un-Resectable Advanced and Metastatic Esophageal Cancer in China

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PCN136 Evaluation of the Extent of Real-World Evidence (RWE) Used Within Health Technology Appraisals (HTA) in Oncology: A Comparative Study of Six HTA Agencies

    Jun 1, 2021, 00:00

  • PNS75 The Evolution of Payer Perceptions of Icer

    Jun 1, 2021, 00:00

  • PIN41 The Public Health Implications of Google Trends and News Coverage for COVID-19 in the Early Epidemic Stage: A Multinational Study in Eight Countries

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PUK8 Water: A Prevention Strategy to Decrease the Economic Burden of Recurrent Cystitis Among Women in the United States of America

    Jun 1, 2021, 00:00

  • PCN181 Real-World Evidence (RWE) in Reimbursement, Pricing, and Health Technology Assessment (HTA) in ASIA. How CAN Rwe Supplement Trial DATA in Oncology Indications in a Premarketing Setting?

    Jun 1, 2021, 00:00

  • PIH18 IMPACT of PCP Screening on EARLY Detection of Pediatric Mental Disorder

    Jun 1, 2021, 00:00

  • PNS9 Estimating Incidence Progressed Patients in Partitioned Survival Models - a Comparison of Three Methodologies

    Jun 1, 2021, 00:00

  • PCN172 Evaluation of Real-World Evidence (RWE) Used within Health Technology Assessments (HTA) in Oncology with Pivotal Single-Arm Trials: A Comparative Study of Six HTA Agencies

    Jun 1, 2021, 00:00

  • PCN84 Comparing the Downstream Costs and Healthcare Utilization Associated with the Use of Low-dose Computed Tomography (LDCT) in Lung Cancer Screening in Patients with and without AlzheimerÂ’s Disease and Related Dementias (ADRD)

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Medical Technologies

    Jun 1, 2021, 00:00

  • Mental Health - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PCN232 Economic Burden Among Breast Cancer Patients in the United States

    Jun 1, 2021, 00:00

  • PDB29 Medication Non-Adherence and Health Literacy Among Medicare Beneficiaries with Type 2 Diabetes

    Jun 1, 2021, 00:00

  • Rare Orphan Diseases - Clinical Outcomes

    Jun 1, 2021, 00:00

  • Surgery - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PRO73 Limitations of Matched Control Groups Using Stabilization Criteria: A Case Study in CAH

    Jun 1, 2021, 00:00

  • PCN240 Healthcare Resource Utilization Associated with Disease Recurrence Among Surgically-Treated Patients with Triple-Negative Breast Cancer

    Jun 1, 2021, 00:00

  • PNS111 Development of the SF-6DV2 Health Utility Survey: Content Validity and Patient Preference

    Jun 1, 2021, 00:00

  • PIN43 Sociodemographic Characteristics Associated with Vaccination for Dengue Fever and Yellow Fever in Brazil: Results from the 2018 National Health and Wellness Survey

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Sensory System Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PNS63 A Longitudinal Study to Identify Potentially Low-Value Clinical Procedures Using Hospital Episode Statistics Linked to Deprivation and Ethnicity in England, 2014/15-2018/19

    Jun 1, 2021, 00:00

  • PRS15 A Cost-Utility Analysis of Dacomitinib As First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 21 L858R Substitution Mutation in China

    Jun 1, 2021, 00:00

  • PCN100 Economic Burden in Patients with Metastatic Cervical Cancer: A Truven MarketScan Database Study

    Jun 1, 2021, 00:00

  • PCN223 Recommendations For The Collection Of Patient-Reported Outcomes (PRO) Data In The Post-Progression And Post-Treatment Setting Following Oncology Clinical Trials

    Jun 1, 2021, 00:00

  • PUK22 Treatment Adherence and Quality of Life in UK Distal Renal Tubular Acidosis Patients

    Jun 1, 2021, 00:00

  • PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods

    Jun 1, 2021, 00:00

  • PNS36 VALUE Based Procurement: A Tool to Make Better Purchasing Decisions after COVID-19

    Jun 1, 2021, 00:00

  • Surgery - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCN59 Health Utility Values in Small Cell Lung Cancer: A Literature Review

    Jun 1, 2021, 00:00

  • PCN7 Analysis of Individual-Level Association of Progression-Free Survival (PFS) and Time to Treatment Failure (TTF) with Overall Survival (OS) for Previously Untreated Advanced Renal Cell Carcinoma Patients in the CheckMate 214 Trial

    Jun 1, 2021, 00:00

  • PBI16 Number Needed to Treat and Incremental Costs per Responder for Biologics in Adult Patients with Active Radiographic Axial Spondyloarthritis in the Russian Federation

    Jun 1, 2021, 00:00

  • Medical Devices - Medical Technologies

    Jun 1, 2021, 00:00

  • PNS43 Have NMPA Priority Review Designations Supported Accelerated Regulatory Approval and Patient Access?

    Jun 1, 2021, 00:00

  • PRS14 Evolution of Direct Medical Costs Associated with Respiratory Syncytial VIRUS Disease in Infants: A Retrospective Database Analysis from 2008 to 2017

    Jun 1, 2021, 00:00

  • Cancer - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PND22 Cost-Utility of Mechanical Thrombectomy after Thrombolysis in Ischemic-Stroke Due to Large Vessel Oclussion in Obras Sociales and Empresas De Medicina Prepaga in Argentina

    Jun 1, 2021, 00:00

  • Multiple Diseases - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PCV14 Examining the Direct and Indirect Healthcare Cost Among Pulmonary Arterial Hypertension Patients

    Jun 1, 2021, 00:00

  • PCN48 Cost-Benefit Analysis of Trilaciclib for the Prevention of Chemotherapy-Induced Myelosuppression in Extensive-Stage Small Cell Lung Cancer

    Jun 1, 2021, 00:00

  • PIN35 Prevalence of COVID-19 vs. Seasonal Influenza: A Population-Based National Survey of US Adults

    Jun 1, 2021, 00:00

  • PNS89 WORTH the Weight: Evaluation of Weighting Strategies in Unanchored Matching-Adjusted Indirect Comparison

    Jun 1, 2021, 00:00

  • AI4 Comparing Machine-Learning Methods for the Prediction of Major Adverse Limb Events and Mortality after a Percutaneous Intervention

    Jun 1, 2021, 00:00

  • CE4 Expanding Evidence Base VS Introducing Heterogeneity in Networks for Network Meta-Analyses: A Simulation Study

    Jun 1, 2021, 00:00

  • PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease

    Jun 1, 2021, 00:00

  • Injury Trauma - Economic Evaluation

    Jun 1, 2021, 00:00

  • PIH25 Comparative Effectiveness Analysis of a Pediatric Co-Management Program

    Jun 1, 2021, 00:00

  • PIH22 Efficacy Of Telephone-Based Educational Intervention On Knowledge Transfer Of COVID-19 Related Health Topics To Elderly Citizens In Hong Kong: A Pilot Study

    Jun 1, 2021, 00:00

  • PCN193 Assessing the Impact of Modeling Non-Disease-Related Mortality on Long-Term Survivorship Rates in Previously Untreated Advanced Melanoma: A Case Study from CheckMate 067

    Jun 1, 2021, 00:00

  • PNS52 Examining US Commercial Health Plans' Use of Step Therapy Protocols for Specialty Drugs: An Empirical Analysis

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PNS77 Transferring Health Technology Assessments from EARLY Adopter to Late Adopter Countries: Recommendations for the Implementation of CED Schemes in Central and Eastern European Countries

    Jun 1, 2021, 00:00

  • PNS45 Pricing and Reimbursement of Innovative Medicines: Challenges and Lessons from South-Eastern Europe

    Jun 1, 2021, 00:00

  • The Use of Decision Analytic Modeling in the Evaluation of Surgical Innovations: A Scoping Review

    Jun 1, 2021, 00:00

  • PMD2 Laparoscopic Radiofrequency Ablation VS Laparoscopic Myomectomy in the Treatment of Symptomatic Uterine Leiomyomas: A Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2021, 00:00

  • PNS6 Saving Lives or the Environment - How about Both? the Role of Health Technology Assessment (HTA) Bodies in Creating Sustainable Healthcare Systems

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa

    Jun 1, 2021, 00:00

  • Infectious Diseases - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PSY13 Relationship between Affected Body Surface Area and Initiation of Systemic Therapy in Psoriasis Patients

    Jun 1, 2021, 00:00

  • PBI13 Cost-Minimization Analysis and Budget Impact of Upadacitinib in the Treatment of Rheumatoid Arthritis in the Brazilian Public Health System

    Jun 1, 2021, 00:00

  • PCN231 Humanistic and Economic Burden in Patients with Chronic Myeloid Leukemia – A Review of the Literature

    Jun 1, 2021, 00:00

  • PRO35 Characterization and Treatment of Immune Thrombocytopenia (ITP) in Europe: A Qualitative Observational Study

    Jun 1, 2021, 00:00

  • PBI8 Economic Impact of an Originator-to-Biosimilar Non-Medical Switch in the Real-World Setting: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • Neurological Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN40 Economic and Clinical Burdens of Recurrence Following Nephrectomy for Intermediate-High or High-Risk Renal Cell Carcinoma (RCC): A Retrospective Administrative Claims Analysis

    Jun 1, 2021, 00:00

  • PIN21 The Cost-Utility of Remote Pulse-Oximeter Monitoring of COVID19 Patients

    Jun 1, 2021, 00:00

  • PSS7 The Economic and Humanistic Burden of Dystrophic Epidermolysis Bullosa (DEB): A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PCN99 Healthcare Costs for Elderly Patients with Lung Cancer and Comorbid Major Depressive Disorder (MDD)

    Jun 1, 2021, 00:00

  • PCN125 Waste of Resources in Cervical and Breast Cancer Screening in JAPAN

    Jun 1, 2021, 00:00

  • Mental Health - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN18 Cetuximab Versus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Effectiveness and Patient-Reported Outcomes Multicohort Study

    Jun 1, 2021, 00:00

  • PCN146 Association of Health Related Quality of Life with Breast Cancer Survival Among Hispanic Population Using Medical Expenditure Panel Survey DATA (2006-2015)

    Jun 1, 2021, 00:00

  • PMH53 A Machine Learning Approach to Understanding How Patient Engagement with a Prescription Digital Therapeutic Relates to Healthcare Resource Utilization in Opioid Use Disorder

    Jun 1, 2021, 00:00

  • PMH19 Evaluation of Symptoms of Depression Amongst People with Substance Use during COVID-19 Lockdown in India: A CROSS-Sectional Study

    Jun 1, 2021, 00:00

  • PRO38 Twenty Years of Clinical Trials in Duchenne Muscular Dystrophy: A Low Clinical Drug Development Success

    Jun 1, 2021, 00:00

  • PUK11 Comparison of Hospitalization Burden of Hyperkalemia in Medicaid Patients By Ethnicity: A Propensity Score Matched Analysis of in-Patient Claims Database

    Jun 1, 2021, 00:00

  • PMU48 The IMPACT of COVID-19 on European Health Technology Assessments

    Jun 1, 2021, 00:00

  • PRO29 Cost-Effectiveness Analysis of Using Hypoxic Stored Red Blood Cells to Reduce the Frequency of Blood Transfusions

    Jun 1, 2021, 00:00

  • PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System

    Jun 1, 2021, 00:00

  • PMD3 The Current Burden of Cataract Surgery and Outcomes of Image-Guided Systems: A Targeted Literature Review

    Jun 1, 2021, 00:00

  • PIN23 Costs-Consequences Analysis of Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia in the Brazilian Private Healthcare System

    Jun 1, 2021, 00:00

  • PMS26 Decision-Making and Experienced Benefits and Risks of Corticosteroids As a Treatment for Duchenne Muscular Dystrophy

    Jun 1, 2021, 00:00

  • PNS39 Positive Decisions by Minister of Health on Increase of Ex-Factory Official Price of Publicly Funded Drugs in Poland Lack Content-Related Justifications - an Analysis of Quality of Justifications of Decisions on Increasing Prices of R ...

    Jun 1, 2021, 00:00

  • PMH12 To Evaluate the Overall Clinical and Economic Burden of Treatment Resistant Depression in Egypt from the Payers Perspective

    Jun 1, 2021, 00:00

  • PND58 Health-Related Quality of Life and Caregiver Burden for Caregivers of Individuals with Neurogenic Orthostatic Hypotension

    Jun 1, 2021, 00:00

  • PCN237 Patterns of Healthcare Resource Utilization (HRU) in Unfit Patients with Acute Myeloid Leukemia (AML) Receiving First-line Systemic Treatment or Best Supportive Care (BSC): A Multicenter International Study (CURRENT)

    Jun 1, 2021, 00:00

  • PCN129 Opioid Utilization in Cancer Survivors: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PND7 Assessing the Comparative Efficacy of INP104 for Acute Treatment of Migraine Attacks: A Matching-Adjusted Indirect Comparison

    Jun 1, 2021, 00:00

  • PND35 Modeling The Economic Impact Of Incorporating AbobotulinumtoxinA Into An Institutional Formulary For FDA-Approved Indications

    Jun 1, 2021, 00:00

  • Neurological Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PNS2 Does the Type of Device Affect Usability or Conceptual Understanding of Patient-Reported Outcomes? Qualitative Evidence and Implications for Bring-Your-Own-Device (BYOD)

    Jun 1, 2021, 00:00

  • PMH13 Healthcare Resource Utilization and Costs before and after Long-Acting Injectable Antipsychotic (LAI) Use in Commercially Insured Young Adults with Schizophrenia

    Jun 1, 2021, 00:00

  • PND61 Caregiver-Reported Outcomes in Alzheimer's Disease and Other Dementias: A Survey of Interventional Clinical Trials of Pharmacologic Therapies

    Jun 1, 2021, 00:00

  • PCV13 A Cost Effectiveness Study of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Egypt for Patients with Previously Untreated Three-Vessel or Left MAIN Coronary Artery Disease: Markov MODEL.

    Jun 1, 2021, 00:00

  • PCN137 Measuring Driving Access to Genetic Counselors and Examining Equity of Coverage

    Jun 1, 2021, 00:00

  • Cancer - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • No Specific Disease - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PIT3 Infections Costs after Surgical Treatment for Tibial Fractures in Spain

    Jun 1, 2021, 00:00

  • PCN233 Concordance of Clinical Vs. Algorithm Based Line of Therapy Determination in Lung Cancer

    Jun 1, 2021, 00:00

  • PMS34 LONG- and Short-TERM Disability and Workers' Compensation Trends for Employees with BONE Diseases in the United States

    Jun 1, 2021, 00:00

  • PCN12 A Systematic Literature Review (SLR) of Clinical Outcomes of Treatments for Adult and Pediatric Relapsed/Refractory (R/R) Classical Hodgkin's Lymphoma (cHL) Patients in the UK

    Jun 1, 2021, 00:00

  • PMS15 Assessing the Reporting Quality of Studies of Health Economic Evaluation Models in Osteoarthritis

    Jun 1, 2021, 00:00

  • PRO69 Real-World Treatments and Health-Related Quality of Life in Patients with Prurigo Nodularis in the Lotus PN Observational Trial

    Jun 1, 2021, 00:00

  • PCN154 Real-World Assessment of the Treatment Patterns, Healthcare Resource Use, and Survival Outcomes Associated with Non-Resectable Advanced Esophageal Cancers in South Korea

    Jun 1, 2021, 00:00

  • PRO18 A Systematic Literature Review of the Economic Burden and Cost Drivers in Pulmonary Arterial Hypertension

    Jun 1, 2021, 00:00

  • PMH31 Universal Screening for Suicidal Thoughts and Behaviors in a Large Healthcare System's Hospital and Emergency Departments

    Jun 1, 2021, 00:00

  • Mental Health - Medical Technologies

    Jun 1, 2021, 00:00

  • PIN61 Switch Patterns Among Patients Claiming Antifungal Therapies for Onychomycosis in Canada

    Jun 1, 2021, 00:00

  • PIN31 Budget-IMPACT Analysis of Letermovir for Preventing Cytomegalovirus in Adult Cytomegalovirus Seropositive Allogeneic Hematopoietic Cell Transplant Recipients in the United States

    Jun 1, 2021, 00:00

  • PDB22 Implications for Access to Insulin and Biosimilars: A Survey on Insulin Prices, Availability and Affordability in the Philippines

    Jun 1, 2021, 00:00

  • PCN113 Prevalence of MET exon 14 (METex14) Skipping in Patients with Advanced NSCLC: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PCN156 Real-World Non-Persistence with Oral Multiple Myeloma Treatments: A Comparative Analysis of Methodologies Using Claims Data

    Jun 1, 2021, 00:00

  • HT3 What is Value? A Systematic Review of Value Assessment Frameworks

    Jun 1, 2021, 00:00

  • PRO41 The Economic and Quality of Life impact of Entrectinib on CNS metastasis control

    Jun 1, 2021, 00:00

  • PDB17 TOTAL Cost of Care and Utilization Among Medicare Fee-for-Service (FFS) Patients with Metastatic Pancreatic Cancer Treated with FDA-Approved/NCCN® Category 1 Regimens at 340B VS. NON-340B Hospitals

    Jun 1, 2021, 00:00

  • PMH23 Epidemiology of Acute Agitation Secondary to Schizophrenia and/or Bipolar Disorder in Patients Presenting to Emergency Departments, a Systematic Literature Review

    Jun 1, 2021, 00:00

  • Medical Devices - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN78 A Set of Systematic and Targeted Reviews to Identify the Burden of Iron Chelation Therapy in Myelodysplastic Syndromes

    Jun 1, 2021, 00:00

  • PIN66 Validating an Agent-Based Simulation Model of Hospital-Acquired Clostridioides Difficile Infection Using Primary Hospital Data

    Jun 1, 2021, 00:00

  • PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria

    Jun 1, 2021, 00:00

  • PMU62 Improved Quality of Life in Children With Progressive Familial Intrahepatic Cholestasis Following 24 Weeks of Treatment With Odevixibat, an Ileal Bile Acid Transporter Inhibitor: Results From the Phase 3 PEDFIC 1 Study

    Jun 1, 2021, 00:00

  • PCN38 A Literature Review Of Recurrent Or Metastatic Cervical Cancer Disease Burden, Treatment Outcomes, And Unmet Needs

    Jun 1, 2021, 00:00

  • PRO17 Cost-Minimization Analysis of Lanreotide Autogel Versus Octreotide LAR in Patients with Acromegaly in the Brazilian Public Health System

    Jun 1, 2021, 00:00

  • Disclosure Information

    Jun 1, 2021, 00:00

  • PCN170 Can Early U.S. Adoption of Cancer Drugs Inform HTA Decision-Making?

    Jun 1, 2021, 00:00

  • PMS10 Trends in Leaves Due to Long- and Short-Term Disability and Workers' Compensation for Employees with Back Pain in the United States

    Jun 1, 2021, 00:00

  • Sensory System Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • RE3 Expectations Versus Reality: How Real-World Data Fits into Budget Impact Analyses

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Clinical Outcomes

    Jun 1, 2021, 00:00

  • Multiple Diseases - Organizational Practices

    Jun 1, 2021, 00:00

  • PND15 Health Care Resource Utilization and Costs Among Patients with Essential Tremor: A Retrospective Observational Study in a United States Commercially Insured and Medicare Advantage Population

    Jun 1, 2021, 00:00

  • PDB26 Applying the Stages of Implementation Completion (SIC) Framework Retrospectively to a Community Pharmacy Clinical Intervention Implementation Project for Scaling up Future Success

    Jun 1, 2021, 00:00

  • PRO47 Understanding the Burden of Long-Chain Fatty Acid Oxidation Disorders for Patients and Caregivers

    Jun 1, 2021, 00:00

  • PIN49 Developing a Predictive Algorithm to Identify the Key Factors Impacting on the Transmission and Fatalities from COVID-19

    Jun 1, 2021, 00:00

  • PIN28 A US Payer Cost-Effectiveness Analysis of Imipenem/Cilastatin/Relebactam Versus Colistin Plus Imipenem/Cilastatin in Patients with Carbapenem-Resistant Bacterial Infections

    Jun 1, 2021, 00:00

  • PND34 Healthcare Utilization and Costs at End-of-Life Among US Medicaid Beneficiaries with Huntington's Disease

    Jun 1, 2021, 00:00

  • PCV4 Comorbidities and Survival Risk Measures of Pulmonary Hypertension (PH) Patients in US-Clinical Care: Real-World Assessments from the Trio Health PH Registry

    Jun 1, 2021, 00:00

  • PMU64 Impact Of The First Demonstration of a Patient-Centered Medical Home (PCMH) In Singapore On Quality Of Life And Patient Activation In Older Adults

    Jun 1, 2021, 00:00

  • PSS12 Understanding the Patient Experience with Anti-VEGF Intravitreal Injections and the Impact on Treatment Maintenan A Qualitative Interview Study

    Jun 1, 2021, 00:00

  • PSU21 Health Resource Utilization and Costs of Rectal Cancer Surgery in Korea

    Jun 1, 2021, 00:00

  • PCN34 Comparative Effectiveness of Docetaxel and Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy: Propensity Score-Matching Analyses from Attraction-3 Trial

    Jun 1, 2021, 00:00

  • IN2 Characteristics of Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) across the Three Waves in the US: A Claims-Based Study Using a Large National Sample

    Jun 1, 2021, 00:00

  • PNS101 Evaluation of Artificial Intelligence within DistillerSR Software As a Second Reviewer for a Systematic Literature Review

    Jun 1, 2021, 00:00

  • PCN123 Hospital Admissions Associated with Cancer Pain and Dementia in Older Adults

    Jun 1, 2021, 00:00

  • PRO30 The Cost-Effectiveness of OTL-200 for the Treatment of Metachromatic Leukodystrophy (MLD)

    Jun 1, 2021, 00:00

  • PCV31 Cost-Effectiveness of Dronedarone for the Treatment of Atrial Fibrillation in China

    Jun 1, 2021, 00:00

  • PNS99 Using an Online Survey to Elicit Preferences in China: Comparison of Different Methods Based on SF-6DV2

    Jun 1, 2021, 00:00

  • PND70 Procedure Coding Versus Pharmacy-Dispensing Claims for Assessing Steroid Use in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Primary Immunodeficiency Diseases (PIDD)

    Jun 1, 2021, 00:00

  • PCN150 Barriers to and Facilitators of Cervical Cancer Screening Among Women in Southeast Asia: a Systematic Review

    Jun 1, 2021, 00:00

  • PUK10 Cost–Utility Analysis of DyeVert Contrast Reduction Systems for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary and/or Peripheral Angiography

    Jun 1, 2021, 00:00

  • CE3 Systematic Review and Indirect Comparison of PD-(L)1 Inhibitors in Combination with Platinum-Based Doublet Chemotherapy (PT-DC) for the First-Line Treatment of Non-Squamous, Non-Small-Cell Lung Cancer (nsqNSCLC)

    Jun 1, 2021, 00:00

  • PND69 Absence Benefit Utilization, Duration of Leaves, and Payments Vary By Benefit and over Time for Short- and Long-Term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States

    Jun 1, 2021, 00:00

  • PNS95 Valuation of Preference-Based Measures: Could Borrowing Strength from Existing Countries' Valuations Produce Better Estimates

    Jun 1, 2021, 00:00

  • PCN211 Health-Related Quality of Life in DLBCL Patients Treated with CAR T-Cell Therapy:

    Jun 1, 2021, 00:00

  • PRO8 Effectiveness and Safety of Teriflunomide in Patients with Multiple Sclerosis: A Real-World Study from WEST China Hospital, China

    Jun 1, 2021, 00:00

  • PNS41 Estimating Administrative Costs Linked to Medical Devices Recalls from the Perspective of the Healthcare Provider

    Jun 1, 2021, 00:00

  • ST3 Development of a Survey-Based Predictive Model for Clinical Dementia Rating in Alzheimer's Disease

    Jun 1, 2021, 00:00

  • PMU31 An Assessment of the Relationship Between Depression and Treatment Satisfaction Among Saudi Acne Vulgaris Patients Using Expectation–Confirmation Theory

    Jun 1, 2021, 00:00

  • PMS23 Preferences of Patients with Rheumatoid Arthritis Are Diverse and Changeable

    Jun 1, 2021, 00:00

  • PRS28 A Scoping Review of Consequences of Untreated Stroke: Economic Burden Due to COVID-19?

    Jun 1, 2021, 00:00

  • Surgery - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PNS27 Amphetamine-Related Hospitalizations in the United States, 2003-2014: Examining Trends and Factors Associated with Admission Outcomes

    Jun 1, 2021, 00:00

  • IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States

    Jun 1, 2021, 00:00

  • Personalized Information Systems

    Jun 1, 2021, 00:00

  • PSU11 Resource Utilization and Disaggregated Cost Analysis of Bariatric Surgery in the Australian Public Healthcare System

    Jun 1, 2021, 00:00

  • PCN32 Comparative Efficacy of Combination of Dabrafenib and Trametinib Against Other Adjuvant Therapies for Melanoma

    Jun 1, 2021, 00:00

  • PND54 A Comparison of NOS and ROBINS-I Tools for Quality Assessment of Observational Studies

    Jun 1, 2021, 00:00

  • PB2 Real-World Adherence to Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy Among Asthma Patients in the US

    Jun 1, 2021, 00:00

  • Multiple Diseases - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PSU9 A Cost-Consequence MODEL of Surgical Nutrition for TOTAL Knee Arthroplasty

    Jun 1, 2021, 00:00

  • PCN107 Economic Burden of Complications Associated with Transthoracic Needle Biopsy of Pulmonary Nodules: A Retrospective Cohort Analysis

    Jun 1, 2021, 00:00

  • PCN33 Real-World Progression-Free Survival by Timing of Molecular Profiling Testing Among Metastatic Non-Small Cell Lung Cancer Patients in a Community Setting

    Jun 1, 2021, 00:00

  • PRO74 Pilot Study of a Novel Patient-facing Medical Records Collection Platform to Support Real World Data Generation in Rare Disease

    Jun 1, 2021, 00:00

  • Mental Health - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • SM2 The Consequences of Greater Net Price Transparency for Innovative Medicines in Europe: Insights from a Multi-Agent Simulation Model

    Jun 1, 2021, 00:00

  • PCV9 Budget IMPACT Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event in the United States

    Jun 1, 2021, 00:00

  • PMU44 Quality of Life and Costs of a Telemedicine Service for Ophthalmologic Diagnoses

    Jun 1, 2021, 00:00

  • PRO28 Healthcare Resource Use (HCRU) of Patients with Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) in France

    Jun 1, 2021, 00:00

  • PMS32 Prediction Models for Surgical Complications Following Total Knee Arthroplasty: Optum PAN-Therapeutic Electronic Health Records

    Jun 1, 2021, 00:00

  • PND4 Real World Evidence to Support the Clinical Effectiveness of Multiple Sclerosis Therapies: A US Perspective

    Jun 1, 2021, 00:00

  • PCN47 Value of Driver Mutation Testing Strategies based on Next-Generation Sequencing (NGS) for Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jun 1, 2021, 00:00

  • PMS3 Risk Factors Associated with Falls and Fractures Followed by Opioid Prescription among Privately-Insured Patients with Osteoarthritis

    Jun 1, 2021, 00:00

  • PNS109 Reducing the Racial/Ethnic Disparities in Personal Health Record (PHR) Adoption in the US

    Jun 1, 2021, 00:00

  • PIN53 Factors that Predispose Individuals to Influenza Virus Infections: A Claims-Based Case-Control Study

    Jun 1, 2021, 00:00

  • PMD18 Reduction in Pedicle SCREW Placement Time with a Guidewireless Pedicle SCREW System for Minimally Invasive SPINE Surgery

    Jun 1, 2021, 00:00

  • MT3 Assessing the Potential Value of Wearable Digital Health Technologies in Chronic Kidney Disease Using Early HTA Methods

    Jun 1, 2021, 00:00

  • PSY8 Calculating Indirect Costs Associated with Moderate and Severe Psoriasis in Russia

    Jun 1, 2021, 00:00

  • PCN11 The potential long-term comparative effectiveness of larotrectinib vs. lenvatinib or sorafenib for treatment of NTRK fusion-positive metastatic thyroid cancer

    Jun 1, 2021, 00:00

  • PGI14 Budget IMPACT Analysis of Tofacitinib in the Treatment of Ulcerative Colitis in the Perspective of Brazilian Public Healthcare System

    Jun 1, 2021, 00:00

  • PND63 Patient Utilities in Parkinson's Disease in Health States Based on Hoehn and Yahr and Off-Time

    Jun 1, 2021, 00:00

  • PCN202 Use of Restricted Mean Survival Time in the Presence of Non-Proportional Hazards As an Alternative Measure of Treatment Benefit in Cost-Effectiveness Analyses

    Jun 1, 2021, 00:00

  • PMU49 Patient Heterogeneity and the Limitations of One-Size-Fits-All Value-Based Pricing: A Systematic Review and Future Directions

    Jun 1, 2021, 00:00

  • Drugs Generics - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PRO21 Burden of Illness in Patients with Light Chain (AL) Amyloidosis: A Real World Study Using Optum Claims Database

    Jun 1, 2021, 00:00

  • PCN213 Systematic Literature Review to Characterize the Burden and Unmet Needs Associated with Cremophor EL

    Jun 1, 2021, 00:00

  • Rare Public Health

    Jun 1, 2021, 00:00

  • PCV6 The Use of Ibuprofen, Including Versus Indomethacin or Paracetamol/Acetaminophen, for the Closure of Patent Ductus Arteriosus in Preterm Infants. a Systematic Review of Meta-Analyses

    Jun 1, 2021, 00:00

  • PNS22 Real-World DATA of ADR Reports in Signal Detection - DME Perspective

    Jun 1, 2021, 00:00

  • Machine Learning Applications in Health

    Jun 1, 2021, 00:00

  • PNS61 The Second Coming of the Nice Appeal Process?

    Jun 1, 2021, 00:00

  • PIN51 Role of Asymptomatic Carriers in the Transmission of COVID-19: A Review

    Jun 1, 2021, 00:00

  • Drugs Generics - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PCN52 Cost-Effectiveness Analysis of the Third-LINE Treatment of Regorafenib for Metastatic or Unresectable Gastrointestinal Stromal Tumors in China

    Jun 1, 2021, 00:00

  • Infectious Diseases - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PRO48 Utilities in a rare disease collected via vignettes in general population samples from the UK and Fran comparison of Results

    Jun 1, 2021, 00:00

  • PMU16 Hospital Outcomes Attributable to Congestive Heart Failure in Patients with Endometrial Cancer in the U.S.: A Retrospective Analysis

    Jun 1, 2021, 00:00

  • PCN79 Healthcare Resource Utilization (HRU) of Immune Checkpoint Inhibitors in Metastatic LUNG Cancer Patients

    Jun 1, 2021, 00:00

  • PCV58 Transcatheter Aortic Valve Implantation VS. Surgical Aortic Valve Replacement for Aortic Stenosis in Taiwan: A Population-Based Cohort Study

    Jun 1, 2021, 00:00

  • PSU6 Cost-Eectiveness Analysis of the Application of Porcine-Derived Fibrin Sealant for the Treatment of IntraOperative Cerebrospinal Fluid Leak in China

    Jun 1, 2021, 00:00

  • PDB35 Trajectory of Glycated Hemoglobin Over Time Among Obese Type 2 Diabetes Patients Prescribed U-100 Basal-only Insulin Regimens: A US Administrative Claims Data Analysis

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCV22 Estimating the Reduction in Medical Care Costs Associated with Ticagrelor and Aspirin in Patients with Acute Ischemic Stroke or TIA

    Jun 1, 2021, 00:00

  • PCN127 What Is the IMPACT of the Introduction of Ipilimumab, Pembrolizumab, and Nivolumab on Malignant Melanoma in Nordics?

    Jun 1, 2021, 00:00

  • CO4 Predictors of Inpatient Relapse in Multiple Sclerosis Patients Using First-Line Disease Modifying Therapies: A Machine Learning Study of Real World Data

    Jun 1, 2021, 00:00

  • PIT5 Cost Savings of Autologous Cell Harvesting Device for the Treatment of Burns Requiring Hospitalization: An Economic Evaluation Using Real-World DATA

    Jun 1, 2021, 00:00

  • PCN139 Value Frameworks and Innovative Contracting for Comprehensive Genomic Profiling

    Jun 1, 2021, 00:00

  • PNS71 Formulary Decision-Maker Survey on Clinician Familiarity with Value Frameworks

    Jun 1, 2021, 00:00

  • PRS10 Economic Evaluation of Umeclidinium/Vilanterol Versus Umeclidinium or Salmeterol in a UK COPD Population at Low Risk of Exacerbations Using the GALAXY Model

    Jun 1, 2021, 00:00

  • ML4 Association of Incident Cancer with Low-Value Care among Elderly Medicare Beneficiaries Using Machine Learning

    Jun 1, 2021, 00:00

  • Infectious Diseases - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PCN147 Impact of Guideline-Concordant Treatment on Survival Among Older Women with Advanced Ovarian Cancer

    Jun 1, 2021, 00:00

  • Medical Devices - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PMU71 Real World Data Availability in Latin America: Assessment and Implications for Research and Healthcare Decision Making

    Jun 1, 2021, 00:00

  • No Specific Disease - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PND38 IMPACT of Remoteness on Cost of Illness of Australians with Multiple Sclerosis

    Jun 1, 2021, 00:00

  • PRO64 Psychometric Validation of the Brief Fatigue Inventory (BFI) and Brief Pain Inventory Short-Form (BPI-SF) in Tumor-Induced Osteomalacia (TIO)

    Jun 1, 2021, 00:00

  • PUK2 Hospitalization in Patients Receiving Maintenance Dialysis with Hyperphosphatemia Randomized to Tenapanor or Sevelamer

    Jun 1, 2021, 00:00

  • PSY11 Systematic Literature Review to Assess Overall Costs and Societal Impacts of Atopic Dermatitis in Europe

    Jun 1, 2021, 00:00

  • Rare Process of Care

    Jun 1, 2021, 00:00

  • PNS49 Are Multiple Brands Used to Charge Higher Prices for Orphan Drug Designations in the US?

    Jun 1, 2021, 00:00

  • PNS46 Development of Consumer-Reported Outcome Measure (CROM) Standards for the Tobacco Industry with Respect to Psychometric CROM Using a Consortium-Based Approach: Methodology and Scope

    Jun 1, 2021, 00:00

  • PGI3 A Network Meta-Analysis to Compare Efficacy of Filgotinib with Other Treatments in Biologic-Naïve Patients with Moderately to Severely Active Ulcerative Colitis

    Jun 1, 2021, 00:00

  • PDG8 Economic Burden of Patients Treated with Dalbavancin in a Spanish Hospital: ECODAL Analysis

    Jun 1, 2021, 00:00

  • PSY5 Comorbidity Related Excess Healthcare Expenditures Among Adults with Psoriasis in the United States: A Propensity Score Matched Analysis

    Jun 1, 2021, 00:00

  • PNS115 Real World Evidence to Support Regulatory Decisions: Frameworks for Latin American Agencies

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PRO60 The Epworth Sleepiness Scale for Children and Adolescents Is a Fit-for-Purpose Measure of Daytime Sleepiness in Prader-Willi Syndrome: A Qualitative Interview Study

    Jun 1, 2021, 00:00

  • PDG30 A Study on Adverse Drug Reaction Related Hospital Admissions of a Tertiary Care Hospital in South India

    Jun 1, 2021, 00:00

  • PNS48 Do US Commercial Health Plans Cite ICER Reports in Their Specialty Drug Coverage Policies? an Empirical Analysis

    Jun 1, 2021, 00:00

  • PMU19 Comparison of Burden of Hospitalizations in Rheumatoid Arthritis (RA), Crohns Disease (CD) and Ulcerative Colitis (CD) Patients Insured By Medicaid: A Propensity Score Matched Analysis of in-Patient Claims Database

    Jun 1, 2021, 00:00

  • PIH14 Statewide Trends in Genetic Testing for Hereditary Cancers in Arkansas 2013-2018

    Jun 1, 2021, 00:00

  • PBI7 Cost-Effectiveness Analysis of Adalimumab Biosimilar Compared to Delayed Biologic Treatment Initiation in Patients with Rheumatoid Arthritis in Germany

    Jun 1, 2021, 00:00

  • PCN214 Responsiveness and Responder Definitions for the NCCN/FACT Bladder Symptom Index (NFBISI-18) in Individuals With Locally Advanced or Metastatic Urothelial Cancer (UC)

    Jun 1, 2021, 00:00

  • PDG36 Predicting Opioid Use Disorder Using Machine Learning Methodologies

    Jun 1, 2021, 00:00

  • Drugs Generics - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Health Technology Assessment Studies

    Jun 1, 2021, 00:00

  • PCN183 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet-Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in Canad ...

    Jun 1, 2021, 00:00

  • PRS19 Trends in Diagnostic Prevalence, Treatment Patterns, and Healthcare Resource Utilization of Adult Patients with Food Allergies in the United States, 2008-2018

    Jun 1, 2021, 00:00

  • PND48 Real World Data and COVID-19: Healthcare Impact in Emergency Care, Stroke Emergency Care and Stroke-Related Deaths in Chile

    Jun 1, 2021, 00:00

  • PNS108 Psychometric Validation of New Scales Expanding Conceptual Coverage of the ABOUTTM-Perceived Risk: Perceived Social Risk and Perceived Practical Risk

    Jun 1, 2021, 00:00

  • PGI9 Using a New Powered Stapling System with Gripping Surface Technology Is Associated with Better Intraoperative Outcomes Among Patients with Gastric Carcinoma

    Jun 1, 2021, 00:00

  • PND21 A Tool Proposal For Measuring Costs Using Time-Driven Activity-Based Costing For The Ischemic Stroke Care Pathway

    Jun 1, 2021, 00:00

  • PDB39 Dosing Patterns Among Patients with Type 2 Diabetes (T2D) Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) in France and the Netherlands

    Jun 1, 2021, 00:00

  • PND37 Cost-Effectiveness of BoNT-A Products for Treatment of Pediatric Spasticity in the United Kingdom

    Jun 1, 2021, 00:00

  • SM4 The New SMC Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?

    Jun 1, 2021, 00:00

  • Cancer - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PMU5 IMPACT of Telehealth Utilization during the COVID-19 Pandemic on Health Care Resource Utilization

    Jun 1, 2021, 00:00

  • Infectious Diseases - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PDB14 Obesity and Their Comorbidities in Chile: An Open Database Analysis to Solve Local Gaps in Clinical Inputs for Economic Evaluations.

    Jun 1, 2021, 00:00

  • PRS27 A Systematic Review on the Impact of Digital Health Technologies in Latent Tuberculosis Infection Management

    Jun 1, 2021, 00:00

  • PCN182 A Partial Mcda Approach to Identify Key Criteria for Brazilian Public Reimbursement Decision in Melanoma Adjuvant Treatment Setting

    Jun 1, 2021, 00:00

  • PCN176 A Multinational Comparison of HTA Decisions for New Treatment Options in Oncology in 2020

    Jun 1, 2021, 00:00

  • PCN92 Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib (N+C) Versus Sunitinib (S) for Previously Untreated Advanced Renal Cell Carcinoma (aRCC)

    Jun 1, 2021, 00:00

  • PND31 Comparison of Burden of Hospitalizations in Epilepsy, Migraine and Sleep Disorders: A Propensity Score Matched Analysis of In-Patient Claims Database

    Jun 1, 2021, 00:00

  • Musculoskeletal Disorders - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PCN51 Annual Healthcare Resource Utilization and Costs in U.S. Patients Diagnosed with Relapsed Acute Myeloid Leukemia

    Jun 1, 2021, 00:00

  • PCV20 Cost-Effectiveness of a Tacrolimus-Mycophenolate Mofetil Regimen for Organ Rejection Prophylaxis in Heart Transplant Recipients in Colombia

    Jun 1, 2021, 00:00

  • PND26 The Cost-Effectiveness of Fremanezumab in Patients with Migraine Who Have Failed Two or More Previous Migraine Preventive Therapies From a UK Healthcare System Perspective

    Jun 1, 2021, 00:00

  • PDG27 A Systematic Review of Concomitant Opioid and Sedative or Skeletal Muscle Relaxant Use on Patient Outcomes in Chronic Non-Malignant Pain

    Jun 1, 2021, 00:00

  • PMH40 Effects of AXS-05 on Patient Reported Depressive Symptoms in Major Depressive Disorder: Results from the GEMINI Trial

    Jun 1, 2021, 00:00

  • PRO25 Trend in Hospital Length of Stay, Costs and Comorbidities in Patients with Veno-Occlusive Disease (VOD): Analysis of National in-Patient Hospital Database

    Jun 1, 2021, 00:00

  • PMH11 Differences in Healthcare Expenditures of Older United States Adults with Self-Reported PAIN between Mental Health Status

    Jun 1, 2021, 00:00

  • PSS17 Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Eye (Ophthalmic) Conditions in the United States

    Jun 1, 2021, 00:00

  • PCN117 Immune-related adverse events (irAEs) in NSCLC patients treated with programmed cell death 1 (PD-1) inhibitors: An analysis using the data from FDA adverse event reporting system (FAERS)

    Jun 1, 2021, 00:00

  • PIN71 Influencing Factors and Economic Burden of Carbapenem Resistant Klebsiella Pneumoniae Pulmonary Infection in Neurosurgical Patients

    Jun 1, 2021, 00:00

  • PND51 Trends and Characteristics in Opioid Analgesic Use for Migraine in US Emergency Departments: Analysis of National Hospital Ambulatory Medical Care Survey 2007-2018 Data

    Jun 1, 2021, 00:00

  • PNS104 Findings from the 2020 Ispor Student Benefit Survey

    Jun 1, 2021, 00:00

  • PDB28 Innovative Application of a Mobile APP for Gestational Diabetes Health Education in the Era of the COVID-19 Pandemic and BIG DATA

    Jun 1, 2021, 00:00

  • PMH22 The Use of Naloxone in Opioid Overdose and Overdose at-Risk Populations: A Retrospective Medical Claims Analysis

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PIH36 How Does Caregiver Burden Change As Alzheimer's Dementia (AD) Severity Advances?

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN161 Continuity of Care, Health Resource Utilization, Cost and Mortality in Medicare Prostate Cancer Patients

    Jun 1, 2021, 00:00

  • CE2 Effect of Different Variance Estimation Methods with Inverse Probability Treatment Weights (IPTW) on Comparative Effectiveness Measure in Multiple Sclerosis

    Jun 1, 2021, 00:00

  • PND36 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Programa De Atencion medica Integral Pami in Argentina

    Jun 1, 2021, 00:00

  • PSU16 Trends in the Adoption of Different Surgical Approaches across Specialties: A National Study from 2013 to 2019

    Jun 1, 2021, 00:00

  • PRO53 Symptoms and impact of aromatic l-amino acid decarboxylase deficiency (AADCd): A qualitative study

    Jun 1, 2021, 00:00

  • Surgery - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PND67 Factors Associated with Prescribing of Disease-Modifying Agents Among Older Adults with Multiple Sclerosis: A Real-World Analysis of Electronic Medical Records

    Jun 1, 2021, 00:00

  • PR3 Identifying Preferences for Closed-Loop Insulin Systems Among Children with Type 1 Diabetes and Their Parents: A Discrete Choice Experiment

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • CO3 Comparison of Goal Attainment and Measures of Function in Two Dementia Clinical Trials.

    Jun 1, 2021, 00:00

  • PND41 Direct Medical Costs of Parkinson's Disease in JAPAN

    Jun 1, 2021, 00:00

  • PRO78 Real-World Treatment Patterns in Patients with Light Chain (AL) Amyloidosis: Analysis of the Optum US Electronic Health Records (EHR) and Commercial Claims Database

    Jun 1, 2021, 00:00

  • Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer

    Jun 1, 2021, 00:00

  • PMU54 A Claims-Based Algorithm to Identify Inadequate Response to Immunomodulatory Therapies Among Patients with Selected Autoimmune Diseases

    Jun 1, 2021, 00:00

  • AI2 The Impact of Including Race and Ethnicity in Risk Prediction Models on Racial Bias

    Jun 1, 2021, 00:00

  • PRO22 Hospital Length of Stay, Total Costs and Comorbidities in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Analysis of National In-patient Hospital Database

    Jun 1, 2021, 00:00

  • RE4 The IMPACT of Reimbursement for NON-Face-to-Face Chronic Care Management on Health Outcomes and Health Care Utilization Among Patients with Type 2 Diabetes in Louisiana

    Jun 1, 2021, 00:00

  • PNS25 Changing in Health Care Service Demand during the COVID-19 Pandemic in 2020: A Study Case of a Subsidized Health Care Company in the Caribbean Region of Colombia

    Jun 1, 2021, 00:00

  • PMU60 Assessing the Readability of Patient-Reported Outcome Measures in Trials for Drugs with Recent FDA Approval

    Jun 1, 2021, 00:00

  • Injury Trauma - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCV34 Cost-Offset Analysis of Dapagliflozin in Treating Heart Failure with Reduced Ejection Fraction (HFREF) in China

    Jun 1, 2021, 00:00

  • Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models

    Jun 1, 2021, 00:00

  • PDG13 Healthcare Expenditures and Resource Utilization Among a Nationally Representative Population of Narcotic Users in the United States, 2008 to 2017

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN75 Cost-Minimization and Budget Impact Analysis of Venetoclax plus Obinutuzumab versus Ibrutinib in High-Risk Patients with Untreated Chronic Lymphocytic Leukemia in the Brazilian Unified Health System (SUS)

    Jun 1, 2021, 00:00

  • PRO10 Indirect Treatment Comparison of Myalepta (Metreleptin) Compared to Best Supportive Care in Lipodystrophy

    Jun 1, 2021, 00:00

  • PDB15 Cost-Effectiveness of a NOVEL Treatment for Diabetic Foot Ulcer Among Patients with Diabetes: A Modeling Study

    Jun 1, 2021, 00:00

  • PSS3 Topline Patient-Reported Outcome Results from a Multicenter, Open-Label, Phase 4 Study of Repository Corticotropin Injection in Patients with Refractory Severe Noninfectious Keratitis

    Jun 1, 2021, 00:00

  • PBI2 Real-World Evaluation of Biosimilar Bevacizumab-awwb versus Reference Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in a U.S. Integrated Healthcare Delivery System: 6-Month Interim Analysis

    Jun 1, 2021, 00:00

  • PMD16 What Factors Do Clinicians Value Most in Selecting Physician Preference Items? a Survey in Orthopedics Using Discrete Choice Experiment and Best-Worst Scaling

    Jun 1, 2021, 00:00

  • PGI13 Economic Burden Associated with Strictures and/or Fistulae Among Commercially Insured Patients Diagnosed with Crohn?s Disease in the US

    Jun 1, 2021, 00:00

  • Clinical Outcome Assessment Studies

    Jun 1, 2021, 00:00

  • PNS8 Evaluating Social Media as a Data Source for Patient Experience Measures: A Study Protocol

    Jun 1, 2021, 00:00

  • PMU21 Factors Related to the Consumption of Antibiotics, a MIXED Methodology Study from the Post Conflicted Areas of SWAT Khyber-Pakhtunkhwa, Pakistan.

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCV10 Cost-Effectiveness of Intensive VS. Moderate Hypertension Treatment in US Adults Age 65 and Older at High Risk of Atherosclerotic Cardiovascular Disease

    Jun 1, 2021, 00:00

  • PCN180 Is the Cancer Drugs Fund Functioning As Anticipated?

    Jun 1, 2021, 00:00

  • PNS26 Explaining Cognitive Impairment Among Adults with Chronic Pain: Non-Linear Decomposition Analysis of 2015 MEPS Data

    Jun 1, 2021, 00:00

  • PNS33 Recommendations for the Design and Implementation of an Early Feasibility Studies Program in Italy

    Jun 1, 2021, 00:00

  • Emerging Methods in Economic Evaluation

    Jun 1, 2021, 00:00

  • PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia

    Jun 1, 2021, 00:00

  • PCN212 Age Disparities in Initial Surgery in Patients with Gliomas: A SEER Analysis

    Jun 1, 2021, 00:00

  • PMH47 Medication Use Patterns Among Adult Mhealth Users with ADHD

    Jun 1, 2021, 00:00

  • PDB11 Real-world cost-effectiveness of SGLT-2 inhibitors versus DPP-4 inhibitors for type 2 diabetes: A modeling study

    Jun 1, 2021, 00:00

  • PCN142 Patient and Caregiver Preferences in Treatment Decision Making in Multiple Myeloma — Results of a Targeted Literature Review

    Jun 1, 2021, 00:00

  • PSS18 Real-World Data Analysis of Dose Escalation and Associated Costs in Biologic Treatment of Psoriasis

    Jun 1, 2021, 00:00

  • PND14 Expanding the Components of Economic Analyses of Pharmacotherapy for Parkinson's Disease

    Jun 1, 2021, 00:00

  • PRS24 Utilizing Blue Cross Blue Shield of Louisiana (BCBSLA) Risk of Hospitalization (ROH) AI Predictive Model to Help Louisiana Identify Patients at High Risk for a COVID-19 Hospital Admission

    Jun 1, 2021, 00:00

  • PCN70 Healthcare Resource Utilization and Costs Among Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Anaplastic Lymphoma Kinase (ALK) Inhibitors

    Jun 1, 2021, 00:00

  • Mental Health - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PCN160 Potential Impact of Advanced Therapy Medicinal Products on Irish Hematology-Oncology Care Pathway

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate

    Jun 1, 2021, 00:00

  • PMH36 Think-Aloud Interviews in Health-Related Resource-Use Research: Application in the PECUNIA Project

    Jun 1, 2021, 00:00

  • No Specific Disease - Medical Technologies

    Jun 1, 2021, 00:00

  • PCN37 An Oncology Real-World Data Assessment Framework for Outcomes Research

    Jun 1, 2021, 00:00

  • PCN153 PhysiciansÂ’ Perceptions and Use of IDH1/2 Mutational Testing and Treatment Selection among Patients with Relapsed or Refractory Acute Myeloid Leukemia in Routine Clinical Practice

    Jun 1, 2021, 00:00

  • PCN5 EARLY-Onset Colorectal Cancer in the United States: A Narrative Review of the Evidence

    Jun 1, 2021, 00:00

  • PGI27 Applying Machine Learning to Large Databases to Predict Nonresponse to Conventional Treatment in Patients with Ulcerative Colitis

    Jun 1, 2021, 00:00

  • PMH14 Association between Substance Use Disorder and Mental Health Service Utilization Among Adults with Major Depressive Disorder Using the National Survey on Drug Use and Health

    Jun 1, 2021, 00:00

  • PCV3 Risk of Obstructive Sleep Apnea in Adults with Treatment Resistant Hypertension: A Population-Based Cohort Study

    Jun 1, 2021, 00:00

  • PMH3 Effects of Antidepressants on Health-Related Quality of Life in Patients with Major Depressive Disorder; A Secondary Analysis Using Perform-J Study

    Jun 1, 2021, 00:00

  • HP4 Dose Medicaid Expansion Provide Affordability of Helathcare Service for Asthma Population

    Jun 1, 2021, 00:00

  • PIN81 Towards a Better Understanding of COVID-19 Among Young Adults Ages 18-24

    Jun 1, 2021, 00:00

  • PCN3 Changes in Transfusion Burden (TB), Hemoglobin (Hb), Serum Ferritin (SF), and Iron Chelation Therapy (ICT) Use in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept From the MEDALIST Stu ...

    Jun 1, 2021, 00:00

  • PCN249 Real World Treatment Patterns of Patients with Ovarian Cancer: Analysis of Targeted Therapies in the French National Claims Data

    Jun 1, 2021, 00:00

  • PNS47 Analysis of Pharmacies Included in the Reimbursement Program in Ukraine

    Jun 1, 2021, 00:00

  • Award Winners

    Jun 1, 2021, 00:00

  • PIN15 Real-World Healthcare Costs of Patients Receiving Dolutegravir/Lamivudine and Other Single Tablet Regimens for the Treatment of HIV-1 in the US

    Jun 1, 2021, 00:00

  • PCV28 Cost-effectiveness Analysis Of Viscoelastic Point-Of-Care Testing Versus Standard Laboratory Tests For Guiding Transfusion Therapy In Brazilian Patients Who Underwent Complex Cardiac Surgery

    Jun 1, 2021, 00:00

  • PIN60 Effect of Community Based Intervention on Isoniazid Preventive Therapy Uptake Among People Living with HIV in FAR Western Province of Nepal: A Cluster Randomized Controlled Trial

    Jun 1, 2021, 00:00

  • PMD6 Procedure Cost-Comparison Analysis of Liquid Embolic System Techniques Using EVOH and n-BCA in the Embolization of Brain Arteriovenous Malformations

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PPM5 The Application of Shared Decision Making in the Chronic Non-Cancer Pain Management: A Systematic Review

    Jun 1, 2021, 00:00

  • PCN86 A Retrospective Observational Analysis of the Healthcare Economic Burden of Patients NEWLY Diagnosed with Hepatocellular Carcinoma and Treated with Locoregional Therapies in the United States

    Jun 1, 2021, 00:00

  • ED2 Elements of Value for Gene Therapy: A Systematic Review

    Jun 1, 2021, 00:00

  • PIH5 Healthcare Resource Utilization Associated with Prematurity: An Analysis of US Medicaid Data

    Jun 1, 2021, 00:00

  • PCN198 Statistical Methods for Pantumor Analysis: Models to Account for Tumor-Level Heterogeneity

    Jun 1, 2021, 00:00

  • CN2 Eliciting Unreported Subgroup-Specific Survival from Aggregate Randomized Controlled Trial Data

    Jun 1, 2021, 00:00

  • PDG6 Budget Impact Analysis for Oliceridine in the Management of Moderate to Severe Acute Postoperative Pain

    Jun 1, 2021, 00:00

  • PCN246 Trends in Prevalence, Treatment Patterns, Myelosuppression, and Burden on the Healthcare System Among Patients with Small Cell Lung Cancer: A SEER-Medicare Analysis

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Economic Evaluation

    Jun 1, 2021, 00:00

  • PNS30 The Humanistic and Economic Costs of Conversion Therapy: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PSU8 Cost-Effectiveness Analysis of Perioperative Goal-Directed Fluid Therapy (PGDT) for High-Risk Hip Replacement Surgery from the Public Healthcare Perspective in Mexico

    Jun 1, 2021, 00:00

  • PIT4 In-HOME IV Antibiotics Cost and Utilization Following Tibia Fractures

    Jun 1, 2021, 00:00
  • «
  • 31
  • 32
  • 33
  • 34
  • 35 (current)
  • 36
  • 37
  • 38
  • 39
  • 40
  • »